Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · Real-Time Price · USD
4.700
+0.070 (1.51%)
May 12, 2025, 4:00 PM - Market closed
POCI Market Cap
POCI has a market cap or net worth of $35.11 million as of May 12, 2025. Its market cap has increased by 3.88% in one year.
Market Cap
35.11M
Enterprise Value
37.99M
1-Year Change
3.88%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since December 1, 1998, POCI's market cap has decreased from $845.70M to $35.11M, a decrease of -95.85%. That is a compound annual growth rate of -11.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 29.50M | -3.59% |
| Dec 31, 2024 | 30.60M | -16.16% |
| Dec 29, 2023 | 36.50M | 16.24% |
| Dec 30, 2022 | 31.40M | -21.70% |
| Dec 31, 2021 | 40.10M | 102.53% |
| Dec 31, 2020 | 19.80M | -14.66% |
| Dec 31, 2019 | 23.20M | 44.10% |
| Dec 31, 2018 | 16.10M | 292.68% |
| Dec 29, 2017 | 4.10M | -6.82% |
| Dec 30, 2016 | 4.40M | -12.00% |
| Dec 31, 2015 | 5.00M | 31.58% |
| Dec 31, 2014 | 3.80M | -5.00% |
| Dec 31, 2013 | 4.00M | 17.65% |
| Dec 31, 2012 | 3.40M | 100.00% |
| Dec 30, 2011 | 1.70M | 750.00% |
| Dec 31, 2010 | 200.00K | -81.82% |
| Dec 31, 2009 | 1.10M | 450.00% |
| Dec 31, 2008 | 200.00K | -94.44% |
| Dec 31, 2007 | 3.60M | -35.71% |
| Dec 29, 2006 | 5.60M | 124.00% |
| Dec 30, 2005 | 2.50M | -71.26% |
| Dec 31, 2004 | 8.70M | -98.63% |
| Dec 31, 2002 | 634.30M | -65.28% |
| Dec 31, 2001 | 1.83B | -69.68% |
| Dec 29, 2000 | 6.03B | -59.57% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |